SidneyYee personal page - To The Moon

SidneyYee

SidneyYee

No personal profile

31Follow

1Followers

0Topic

0Badge

2021-07-26

Great advice!

Sorry, the original content has been removed

2021-07-21

This is great news

Sorry, the original content has been removed

2021-07-20

Up, up and away!

Gold Up, Boosted by Ongoing COVID-19 Worries

2021-07-18

Trust in Fauzi

Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?

2021-07-17

Buy the dip!

Sorry, the original content has been removed

2021-07-17

To the moon!

Sorry, the original content has been removed

2021-07-15

How are the taxes on dividend income handled with tiger brokers?

19 dividend stocks to help you combat inflation

2021-07-15

Thanks

Sorry, the original content has been removed

2021-07-09

Hope to build positions in outstanding Chinese companies during this time of uncertainty!

China stocks slip after inflation data

2021-06-26

Love Tesla!

Sorry, the original content has been removed

2021-06-26

Hope to add to my portfolio

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3572785254205295","uuid":"3572785254205295","gmtCreate":1609691825590,"gmtModify":1625824601664,"name":"SidneyYee","pinyin":"sidneyyee","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":31,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.12","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":800623804,"gmtCreate":1627299466508,"gmtModify":1703487060907,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Great advice!","listText":"Great advice!","text":"Great advice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/800623804","repostId":"2154454934","repostType":4,"isVote":1,"tweetType":1,"viewCount":2801,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176021480,"gmtCreate":1626847335240,"gmtModify":1703479215908,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"This is great news","listText":"This is great news","text":"This is great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176021480","repostId":"1196827638","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171476592,"gmtCreate":1626760697416,"gmtModify":1703764689501,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Up, up and away!","listText":"Up, up and away!","text":"Up, up and away!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171476592","repostId":"1101815579","repostType":4,"repost":{"id":"1101815579","kind":"news","pubTimestamp":1626757956,"share":"https://ttm.financial/m/news/1101815579?lang=en_US&edition=fundamental","pubTime":"2021-07-20 13:12","market":"hk","language":"en","title":"Gold Up, Boosted by Ongoing COVID-19 Worries","url":"https://stock-news.laohu8.com/highlight/detail?id=1101815579","media":"investing.com","summary":"Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreak","content":"<p>Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreaks involving the Delta variant in several countries also gave the safe-haven yellow metal a boost.</p>\n<p>Gold futures&nbsp;were up 0.51% to $1,818.50 by 1:05 PM ET (5:05 AM GMT) after falling to a one-week low of $1,794.06 during the previous session.</p>\n<p>The&nbsp;dollar, which normally moves inversely to gold, inched down on Tuesday but remained near a three-and-a-half-month peak. Benchmark 10-year U.S. Treasury yields fell to near five-month lows.</p>\n<p>In Asia, the&nbsp;People's Bank of China&nbsp;also kept its July loan prime rate&nbsp;(LPR) unchanged for the fifteenth straight month, with the one-year LPR at 3.85% and the five-year LPR at 4.65%. The European Central Bank and Bank Indonesia will also hand down their respective policy decision on Thursday.</p>\n<p>Japan’s&nbsp;national core consumer price index (CPI)&nbsp;grew 0.2% year-on-year in June, the fastest annual pace in over a year, according to data released earlier in the day. The data also saidnational CPIgrowth remained unchanged at 0.3% month-on-month.</p>\n<p>On the stimulus front, U.S. Senate Democratic leader Chuck Schumer said on Monday that he would set a procedural vote on a bipartisan, $1.2 trillion infrastructure bill for Wednesday.</p>\n<p>In other precious metals, silver eased 0.1%, palladium was steady at $2,597.23, and platinum rose 0.3% to $1,077.98.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold Up, Boosted by Ongoing COVID-19 Worries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold Up, Boosted by Ongoing COVID-19 Worries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 13:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investing.com/news/commodities-news/gold-up-boosted-by-ongoing-covid19-worries-2562304><strong>investing.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreaks involving the Delta variant in several countries also gave the safe-haven yellow metal a boost.\n...</p>\n\n<a href=\"https://www.investing.com/news/commodities-news/gold-up-boosted-by-ongoing-covid19-worries-2562304\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.investing.com/news/commodities-news/gold-up-boosted-by-ongoing-covid19-worries-2562304","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101815579","content_text":"Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreaks involving the Delta variant in several countries also gave the safe-haven yellow metal a boost.\nGold futures were up 0.51% to $1,818.50 by 1:05 PM ET (5:05 AM GMT) after falling to a one-week low of $1,794.06 during the previous session.\nThe dollar, which normally moves inversely to gold, inched down on Tuesday but remained near a three-and-a-half-month peak. Benchmark 10-year U.S. Treasury yields fell to near five-month lows.\nIn Asia, the People's Bank of China also kept its July loan prime rate (LPR) unchanged for the fifteenth straight month, with the one-year LPR at 3.85% and the five-year LPR at 4.65%. The European Central Bank and Bank Indonesia will also hand down their respective policy decision on Thursday.\nJapan’s national core consumer price index (CPI) grew 0.2% year-on-year in June, the fastest annual pace in over a year, according to data released earlier in the day. The data also saidnational CPIgrowth remained unchanged at 0.3% month-on-month.\nOn the stimulus front, U.S. Senate Democratic leader Chuck Schumer said on Monday that he would set a procedural vote on a bipartisan, $1.2 trillion infrastructure bill for Wednesday.\nIn other precious metals, silver eased 0.1%, palladium was steady at $2,597.23, and platinum rose 0.3% to $1,077.98.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173089819,"gmtCreate":1626585695831,"gmtModify":1703762080224,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Trust in Fauzi","listText":"Trust in Fauzi","text":"Trust in Fauzi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/173089819","repostId":"2152811496","repostType":4,"repost":{"id":"2152811496","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626548760,"share":"https://ttm.financial/m/news/2152811496?lang=en_US&edition=fundamental","pubTime":"2021-07-18 03:06","market":"us","language":"en","title":"Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?","url":"https://stock-news.laohu8.com/highlight/detail?id=2152811496","media":"Dow Jones","summary":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' s","content":"<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-18 03:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","JNJ":"强生","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152811496","content_text":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert\nA very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.\nPfizer $(PFE)$ last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.\nHealth officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.\n\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.\nDr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.\nAnd, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.\nBut if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.\n\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"\nThe vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.\n\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.\nThe case for boosters is complicated\nMany public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.\nSome experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.\n\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"\nThis discussion is already playing out in other countries.\nA group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.\nIn the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson & Johnson $(JNJ)$, Moderna $(MRNA)$, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.\n\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"\nModerna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.\nPfizer has not announced any deals that include boosters with the U.S.\n\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.\nHow long does immunity from vaccines last?\nIn a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.\nThese include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?\nTo further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.\n\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"\nPfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least one year of protection.\n\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"\nSee now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable","news_type":1,"symbols_score_info":{"JNJ":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2543,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179209144,"gmtCreate":1626527261088,"gmtModify":1703761468662,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Buy the dip!","listText":"Buy the dip!","text":"Buy the dip!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/179209144","repostId":"1198202103","repostType":4,"isVote":1,"tweetType":1,"viewCount":3237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179200850,"gmtCreate":1626527180870,"gmtModify":1703761466070,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"To the moon!","listText":"To the moon!","text":"To the moon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/179200850","repostId":"2152168594","repostType":4,"isVote":1,"tweetType":1,"viewCount":3061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147320439,"gmtCreate":1626336289021,"gmtModify":1703758133101,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"How are the taxes on dividend income handled with tiger brokers?","listText":"How are the taxes on dividend income handled with tiger brokers?","text":"How are the taxes on dividend income handled with tiger brokers?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147320439","repostId":"2151751740","repostType":4,"repost":{"id":"2151751740","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626280020,"share":"https://ttm.financial/m/news/2151751740?lang=en_US&edition=fundamental","pubTime":"2021-07-15 00:27","market":"hk","language":"en","title":"19 dividend stocks to help you combat inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=2151751740","media":"Dow Jones","summary":"These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S","content":"<blockquote>\n These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S. Treasury notes.\n</blockquote>\n<p>How can you avoid inflation, or at least make up for it?</p>\n<p>Consumers and investors may be alarmed by rising prices. But a combination of prudent spending and investing can help these overlapping groups of people get through a period of uncertainty brought about by pent-up demand and supply shortages.</p>\n<p>Below are two lists of 19 dividend stocks with attractive yields -- companies that are expected to have plenty of cash flow to cover dividend increases or other actions that may be good for shareholders, including stock repurchases and business expansion.</p>\n<p>The consumer price index rose by 0.9% in only <a href=\"https://laohu8.com/S/AONE\">one</a> month . It's easy to say that you shouldn't buy a car or truck this year. The incredible demand for used vehicles has led to a shortage for many of the most popular new ones, which means dealers will be less likely to haggle.</p>\n<p>Of course you might be in a pickle and need to get another car or truck at the worst time, but maybe you can make a modest selection this time. You might also delay a plan to sell your home and move into a bigger <a href=\"https://laohu8.com/S/AONE.U\">one</a>, considering that every other national housing boom you have ever witnessed has eventually cooled. In other words, it is possible some of your big spending plans can be curbed or delayed.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> dividend stock screens</p>\n<p>What do you want from a dividend stock? The most obvious answer is \"income,\" but what may be more important is that the dividend increases over time. That's how you stay ahead of inflation. Even when official inflation figures are low, your personal inflation can be considerable, depending on your circumstances. Or you may need investment income to replace part of your working income when you retire.</p>\n<p>Here's a recent list of the 30 stocks in the S&amp;P 500 index whose dividends increased the most over the past five years . Their dividend yields may not have been very high to begin with, but if you had held them for five years, the yields on your five-year-old shares would have grown significantly.</p>\n<p>For this new screen, we took a different approach to focus more on higher current dividend yields. Beginning with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P Mid Cap 400 Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index ), we started with stocks with dividend yields of at least 4.26% -- three times the 1.42% yield on 10-year U.S. Treasury notes on July 13.</p>\n<p>Then we looked at free cash flow yields. A company's free cash flow is its remaining cash flow after planned capital expenditures. It can be used to increase dividends, buy back stock, pay down debt, business expansion or fund acquisitions. A free cash flow yield that is higher than the dividend yield can provide investors with some comfort that a company is unlikely to cut its dividend and maybe be in a position to increase it.</p>\n<p>A trailing free cash flow yield can be calculated by dividing the past four quarters' free cash flow per share by the current share price. If available, consensus estimates for the next 12 months can be used to calculate a forward FCF yield. If the FCF yield is above the current dividend yield, there is free cash flow \"headroom.\" (The screen below only includes companies for which forward FCF estimates were available from FactSet.)</p>\n<p>Financial companies were excluded from the screen, as FCF yield analysis isn't appropriate for the group. Companies with fewer than five analysts polled for FactSet's estimates were also excluded. For real estate investment trusts, funds from operations (FFO) is the industry standard for gauging dividend-paying ability. So there is a separate screen for that group below.</p>\n<p>Starting with the S&amp;P Composite 1500, here are the eight stocks that made the cut, with dividend yields of at least 4.26%, positive forward and trailing FCF \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet. The list is sorted by dividend yield:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Dividend yield</td>\n   <td>Forward FCF yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FCF yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td>Williams Cos. Inc. WMB</td>\n   <td>6.26%</td>\n   <td>9.08%</td>\n   <td>2.82%</td>\n   <td>7.53%</td>\n   <td>1.27%</td>\n  </tr>\n  <tr>\n   <td>B&amp;G Foods Inc. BGS</td>\n   <td>6.20%</td>\n   <td>11.44%</td>\n   <td>5.24%</td>\n   <td>11.00%</td>\n   <td>4.80%</td>\n  </tr>\n  <tr>\n   <td>Kinder Morgan Inc. Class P KMI</td>\n   <td>5.91%</td>\n   <td>9.86%</td>\n   <td>3.95%</td>\n   <td>9.98%</td>\n   <td>4.07%</td>\n  </tr>\n  <tr>\n   <td>H&amp;R Block Inc. HRB</td>\n   <td>4.57%</td>\n   <td>14.83%</td>\n   <td>10.25%</td>\n   <td>13.28%</td>\n   <td>8.71%</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications Inc. VZ</td>\n   <td>4.47%</td>\n   <td>7.84%</td>\n   <td>3.37%</td>\n   <td>10.86%</td>\n   <td>6.38%</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>4.47%</td>\n   <td>9.66%</td>\n   <td>5.19%</td>\n   <td>7.64%</td>\n   <td>3.18%</td>\n  </tr>\n  <tr>\n   <td>LyondellBasell Industries NV LYB</td>\n   <td>4.43%</td>\n   <td>10.82%</td>\n   <td>6.39%</td>\n   <td>5.30%</td>\n   <td>0.87%</td>\n  </tr>\n  <tr>\n   <td>AbbVie Inc. ABBV</td>\n   <td>4.41%</td>\n   <td>10.19%</td>\n   <td>5.77%</td>\n   <td>8.61%</td>\n   <td>4.20%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Click on the tickers for more about each company, including news, business profiles, price ratios and ratings.</p>\n<p>In case you are wondering about AT&amp;T Inc. <a href=\"https://laohu8.com/S/T\">$(T)$</a> -- known for its high dividend yield over the long term -- the company hasn't yet announced a dividend cut but said in March that as part of its plan to divest its WarnerMedia properties, it was going to \"resize \" the dividend, taking it down to a payout ratio of about 40% to 43% of free cash flow.</p>\n<p>We don't have the figures to predict how high the slimmed-down company's dividend might be after AT&amp;T's deals are completed, but the yield on the shares as of the close on July 13 was 7.36%, while its forward FCF yield was 11.79%. Ordinarily that would appear to be plenty of headroom to support the dividend. But it implies a payout ratio of 62%, which is much higher than the ratio of the current yield to the forward FCF yield.</p>\n<p>REITs</p>\n<p>For a second screen of real estate investment trusts, we used funds from operations (FFO) instead of free cash flow. FFO adds depreciation on real estate to earnings and nets out gains or losses on the sale of property. Here are the 10 highest-yielding REITs in the S&amp;P Composite 1500 with positive forward and trailing FFO \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet:</p>\n<table>\n <tbody>\n  <tr>\n   <td>REIT</td>\n   <td>Dividend yield</td>\n   <td>Forward FFO yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FFO yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/OHI\">Omega Healthcare Investors</a> Inc. OHI</td>\n   <td>7.27%</td>\n   <td>9.08%</td>\n   <td>1.81%</td>\n   <td>8.93%</td>\n   <td>1.65%</td>\n  </tr>\n  <tr>\n   <td>LTC Properties Inc. LTC</td>\n   <td>5.88%</td>\n   <td>7.00%</td>\n   <td>1.12%</td>\n   <td>5.91%</td>\n   <td>0.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MPW\">Medical Properties Trust</a> Inc. MPW</td>\n   <td>5.58%</td>\n   <td>8.91%</td>\n   <td>3.33%</td>\n   <td>8.07%</td>\n   <td>2.49%</td>\n  </tr>\n  <tr>\n   <td>Brandywine Realty Trust BDN</td>\n   <td>5.44%</td>\n   <td>9.98%</td>\n   <td>4.55%</td>\n   <td>10.01%</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DOC\">Physicians Realty Trust</a> DOC</td>\n   <td>4.99%</td>\n   <td>6.02%</td>\n   <td>1.03%</td>\n   <td>5.75%</td>\n   <td>0.76%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ILPT\">Industrial Logistics Properties Trust</a></td>\n   <td>4.97%</td>\n   <td>7.10%</td>\n   <td>2.14%</td>\n   <td>7.00%</td>\n   <td>2.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GTY\">Getty Realty Corp</a>. GTY</td>\n   <td>4.91%</td>\n   <td>6.16%</td>\n   <td>1.26%</td>\n   <td>7.14%</td>\n   <td>2.23%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DEA\">Easterly Government Properties Inc</a>. DEA</td>\n   <td>4.83%</td>\n   <td>6.14%</td>\n   <td>1.31%</td>\n   <td>5.95%</td>\n   <td>1.12%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SLG\">SL Green Realty Corp</a>. SLG</td>\n   <td>4.71%</td>\n   <td>8.73%</td>\n   <td>4.03%</td>\n   <td>8.89%</td>\n   <td>4.18%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/CTRE\">CareTrust REIT Inc.</a> CTRE</td>\n   <td>4.48%</td>\n   <td>6.49%</td>\n   <td>2.00%</td>\n   <td>5.92%</td>\n   <td>1.44%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>As always, you should do your own research before considering any stock for investment. For the REITs, it is especially important to consider a company's investment focus. Whether it is retail, office property, health-care property or another area, each has its own opportunities and challenges.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>19 dividend stocks to help you combat inflation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n19 dividend stocks to help you combat inflation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-15 00:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S. Treasury notes.\n</blockquote>\n<p>How can you avoid inflation, or at least make up for it?</p>\n<p>Consumers and investors may be alarmed by rising prices. But a combination of prudent spending and investing can help these overlapping groups of people get through a period of uncertainty brought about by pent-up demand and supply shortages.</p>\n<p>Below are two lists of 19 dividend stocks with attractive yields -- companies that are expected to have plenty of cash flow to cover dividend increases or other actions that may be good for shareholders, including stock repurchases and business expansion.</p>\n<p>The consumer price index rose by 0.9% in only <a href=\"https://laohu8.com/S/AONE\">one</a> month . It's easy to say that you shouldn't buy a car or truck this year. The incredible demand for used vehicles has led to a shortage for many of the most popular new ones, which means dealers will be less likely to haggle.</p>\n<p>Of course you might be in a pickle and need to get another car or truck at the worst time, but maybe you can make a modest selection this time. You might also delay a plan to sell your home and move into a bigger <a href=\"https://laohu8.com/S/AONE.U\">one</a>, considering that every other national housing boom you have ever witnessed has eventually cooled. In other words, it is possible some of your big spending plans can be curbed or delayed.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> dividend stock screens</p>\n<p>What do you want from a dividend stock? The most obvious answer is \"income,\" but what may be more important is that the dividend increases over time. That's how you stay ahead of inflation. Even when official inflation figures are low, your personal inflation can be considerable, depending on your circumstances. Or you may need investment income to replace part of your working income when you retire.</p>\n<p>Here's a recent list of the 30 stocks in the S&amp;P 500 index whose dividends increased the most over the past five years . Their dividend yields may not have been very high to begin with, but if you had held them for five years, the yields on your five-year-old shares would have grown significantly.</p>\n<p>For this new screen, we took a different approach to focus more on higher current dividend yields. Beginning with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P Mid Cap 400 Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index ), we started with stocks with dividend yields of at least 4.26% -- three times the 1.42% yield on 10-year U.S. Treasury notes on July 13.</p>\n<p>Then we looked at free cash flow yields. A company's free cash flow is its remaining cash flow after planned capital expenditures. It can be used to increase dividends, buy back stock, pay down debt, business expansion or fund acquisitions. A free cash flow yield that is higher than the dividend yield can provide investors with some comfort that a company is unlikely to cut its dividend and maybe be in a position to increase it.</p>\n<p>A trailing free cash flow yield can be calculated by dividing the past four quarters' free cash flow per share by the current share price. If available, consensus estimates for the next 12 months can be used to calculate a forward FCF yield. If the FCF yield is above the current dividend yield, there is free cash flow \"headroom.\" (The screen below only includes companies for which forward FCF estimates were available from FactSet.)</p>\n<p>Financial companies were excluded from the screen, as FCF yield analysis isn't appropriate for the group. Companies with fewer than five analysts polled for FactSet's estimates were also excluded. For real estate investment trusts, funds from operations (FFO) is the industry standard for gauging dividend-paying ability. So there is a separate screen for that group below.</p>\n<p>Starting with the S&amp;P Composite 1500, here are the eight stocks that made the cut, with dividend yields of at least 4.26%, positive forward and trailing FCF \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet. The list is sorted by dividend yield:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Dividend yield</td>\n   <td>Forward FCF yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FCF yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td>Williams Cos. Inc. WMB</td>\n   <td>6.26%</td>\n   <td>9.08%</td>\n   <td>2.82%</td>\n   <td>7.53%</td>\n   <td>1.27%</td>\n  </tr>\n  <tr>\n   <td>B&amp;G Foods Inc. BGS</td>\n   <td>6.20%</td>\n   <td>11.44%</td>\n   <td>5.24%</td>\n   <td>11.00%</td>\n   <td>4.80%</td>\n  </tr>\n  <tr>\n   <td>Kinder Morgan Inc. Class P KMI</td>\n   <td>5.91%</td>\n   <td>9.86%</td>\n   <td>3.95%</td>\n   <td>9.98%</td>\n   <td>4.07%</td>\n  </tr>\n  <tr>\n   <td>H&amp;R Block Inc. HRB</td>\n   <td>4.57%</td>\n   <td>14.83%</td>\n   <td>10.25%</td>\n   <td>13.28%</td>\n   <td>8.71%</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications Inc. VZ</td>\n   <td>4.47%</td>\n   <td>7.84%</td>\n   <td>3.37%</td>\n   <td>10.86%</td>\n   <td>6.38%</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>4.47%</td>\n   <td>9.66%</td>\n   <td>5.19%</td>\n   <td>7.64%</td>\n   <td>3.18%</td>\n  </tr>\n  <tr>\n   <td>LyondellBasell Industries NV LYB</td>\n   <td>4.43%</td>\n   <td>10.82%</td>\n   <td>6.39%</td>\n   <td>5.30%</td>\n   <td>0.87%</td>\n  </tr>\n  <tr>\n   <td>AbbVie Inc. ABBV</td>\n   <td>4.41%</td>\n   <td>10.19%</td>\n   <td>5.77%</td>\n   <td>8.61%</td>\n   <td>4.20%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Click on the tickers for more about each company, including news, business profiles, price ratios and ratings.</p>\n<p>In case you are wondering about AT&amp;T Inc. <a href=\"https://laohu8.com/S/T\">$(T)$</a> -- known for its high dividend yield over the long term -- the company hasn't yet announced a dividend cut but said in March that as part of its plan to divest its WarnerMedia properties, it was going to \"resize \" the dividend, taking it down to a payout ratio of about 40% to 43% of free cash flow.</p>\n<p>We don't have the figures to predict how high the slimmed-down company's dividend might be after AT&amp;T's deals are completed, but the yield on the shares as of the close on July 13 was 7.36%, while its forward FCF yield was 11.79%. Ordinarily that would appear to be plenty of headroom to support the dividend. But it implies a payout ratio of 62%, which is much higher than the ratio of the current yield to the forward FCF yield.</p>\n<p>REITs</p>\n<p>For a second screen of real estate investment trusts, we used funds from operations (FFO) instead of free cash flow. FFO adds depreciation on real estate to earnings and nets out gains or losses on the sale of property. Here are the 10 highest-yielding REITs in the S&amp;P Composite 1500 with positive forward and trailing FFO \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet:</p>\n<table>\n <tbody>\n  <tr>\n   <td>REIT</td>\n   <td>Dividend yield</td>\n   <td>Forward FFO yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FFO yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/OHI\">Omega Healthcare Investors</a> Inc. OHI</td>\n   <td>7.27%</td>\n   <td>9.08%</td>\n   <td>1.81%</td>\n   <td>8.93%</td>\n   <td>1.65%</td>\n  </tr>\n  <tr>\n   <td>LTC Properties Inc. LTC</td>\n   <td>5.88%</td>\n   <td>7.00%</td>\n   <td>1.12%</td>\n   <td>5.91%</td>\n   <td>0.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MPW\">Medical Properties Trust</a> Inc. MPW</td>\n   <td>5.58%</td>\n   <td>8.91%</td>\n   <td>3.33%</td>\n   <td>8.07%</td>\n   <td>2.49%</td>\n  </tr>\n  <tr>\n   <td>Brandywine Realty Trust BDN</td>\n   <td>5.44%</td>\n   <td>9.98%</td>\n   <td>4.55%</td>\n   <td>10.01%</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DOC\">Physicians Realty Trust</a> DOC</td>\n   <td>4.99%</td>\n   <td>6.02%</td>\n   <td>1.03%</td>\n   <td>5.75%</td>\n   <td>0.76%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ILPT\">Industrial Logistics Properties Trust</a></td>\n   <td>4.97%</td>\n   <td>7.10%</td>\n   <td>2.14%</td>\n   <td>7.00%</td>\n   <td>2.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GTY\">Getty Realty Corp</a>. GTY</td>\n   <td>4.91%</td>\n   <td>6.16%</td>\n   <td>1.26%</td>\n   <td>7.14%</td>\n   <td>2.23%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DEA\">Easterly Government Properties Inc</a>. DEA</td>\n   <td>4.83%</td>\n   <td>6.14%</td>\n   <td>1.31%</td>\n   <td>5.95%</td>\n   <td>1.12%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SLG\">SL Green Realty Corp</a>. SLG</td>\n   <td>4.71%</td>\n   <td>8.73%</td>\n   <td>4.03%</td>\n   <td>8.89%</td>\n   <td>4.18%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/CTRE\">CareTrust REIT Inc.</a> CTRE</td>\n   <td>4.48%</td>\n   <td>6.49%</td>\n   <td>2.00%</td>\n   <td>5.92%</td>\n   <td>1.44%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>As always, you should do your own research before considering any stock for investment. For the REITs, it is especially important to consider a company's investment focus. Whether it is retail, office property, health-care property or another area, each has its own opportunities and challenges.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KMI":"金德尔摩根","T":"At&T","ABBV":"艾伯维公司","WMB":"威廉姆斯","VZ":"Verizon Comms","TERN":"Terns Pharmaceuticals, Inc.","CRCT":"Cricut, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151751740","content_text":"These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S. Treasury notes.\n\nHow can you avoid inflation, or at least make up for it?\nConsumers and investors may be alarmed by rising prices. But a combination of prudent spending and investing can help these overlapping groups of people get through a period of uncertainty brought about by pent-up demand and supply shortages.\nBelow are two lists of 19 dividend stocks with attractive yields -- companies that are expected to have plenty of cash flow to cover dividend increases or other actions that may be good for shareholders, including stock repurchases and business expansion.\nThe consumer price index rose by 0.9% in only one month . It's easy to say that you shouldn't buy a car or truck this year. The incredible demand for used vehicles has led to a shortage for many of the most popular new ones, which means dealers will be less likely to haggle.\nOf course you might be in a pickle and need to get another car or truck at the worst time, but maybe you can make a modest selection this time. You might also delay a plan to sell your home and move into a bigger one, considering that every other national housing boom you have ever witnessed has eventually cooled. In other words, it is possible some of your big spending plans can be curbed or delayed.\nTwo dividend stock screens\nWhat do you want from a dividend stock? The most obvious answer is \"income,\" but what may be more important is that the dividend increases over time. That's how you stay ahead of inflation. Even when official inflation figures are low, your personal inflation can be considerable, depending on your circumstances. Or you may need investment income to replace part of your working income when you retire.\nHere's a recent list of the 30 stocks in the S&P 500 index whose dividends increased the most over the past five years . Their dividend yields may not have been very high to begin with, but if you had held them for five years, the yields on your five-year-old shares would have grown significantly.\nFor this new screen, we took a different approach to focus more on higher current dividend yields. Beginning with the S&P Composite 1500 Index (made up of the S&P 500 , the S&P Mid Cap 400 Index $(MID)$ and the S&P Small Cap 600 Index ), we started with stocks with dividend yields of at least 4.26% -- three times the 1.42% yield on 10-year U.S. Treasury notes on July 13.\nThen we looked at free cash flow yields. A company's free cash flow is its remaining cash flow after planned capital expenditures. It can be used to increase dividends, buy back stock, pay down debt, business expansion or fund acquisitions. A free cash flow yield that is higher than the dividend yield can provide investors with some comfort that a company is unlikely to cut its dividend and maybe be in a position to increase it.\nA trailing free cash flow yield can be calculated by dividing the past four quarters' free cash flow per share by the current share price. If available, consensus estimates for the next 12 months can be used to calculate a forward FCF yield. If the FCF yield is above the current dividend yield, there is free cash flow \"headroom.\" (The screen below only includes companies for which forward FCF estimates were available from FactSet.)\nFinancial companies were excluded from the screen, as FCF yield analysis isn't appropriate for the group. Companies with fewer than five analysts polled for FactSet's estimates were also excluded. For real estate investment trusts, funds from operations (FFO) is the industry standard for gauging dividend-paying ability. So there is a separate screen for that group below.\nStarting with the S&P Composite 1500, here are the eight stocks that made the cut, with dividend yields of at least 4.26%, positive forward and trailing FCF \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet. The list is sorted by dividend yield:\n\n\n\nCompany\nDividend yield\nForward FCF yield\nForward \"headroom\"\nTrailing FCF yield\nTrailing \"headroom\"\n\n\nWilliams Cos. Inc. WMB\n6.26%\n9.08%\n2.82%\n7.53%\n1.27%\n\n\nB&G Foods Inc. BGS\n6.20%\n11.44%\n5.24%\n11.00%\n4.80%\n\n\nKinder Morgan Inc. Class P KMI\n5.91%\n9.86%\n3.95%\n9.98%\n4.07%\n\n\nH&R Block Inc. HRB\n4.57%\n14.83%\n10.25%\n13.28%\n8.71%\n\n\nVerizon Communications Inc. VZ\n4.47%\n7.84%\n3.37%\n10.86%\n6.38%\n\n\nDow Inc. DOW\n4.47%\n9.66%\n5.19%\n7.64%\n3.18%\n\n\nLyondellBasell Industries NV LYB\n4.43%\n10.82%\n6.39%\n5.30%\n0.87%\n\n\nAbbVie Inc. ABBV\n4.41%\n10.19%\n5.77%\n8.61%\n4.20%\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\nClick on the tickers for more about each company, including news, business profiles, price ratios and ratings.\nIn case you are wondering about AT&T Inc. $(T)$ -- known for its high dividend yield over the long term -- the company hasn't yet announced a dividend cut but said in March that as part of its plan to divest its WarnerMedia properties, it was going to \"resize \" the dividend, taking it down to a payout ratio of about 40% to 43% of free cash flow.\nWe don't have the figures to predict how high the slimmed-down company's dividend might be after AT&T's deals are completed, but the yield on the shares as of the close on July 13 was 7.36%, while its forward FCF yield was 11.79%. Ordinarily that would appear to be plenty of headroom to support the dividend. But it implies a payout ratio of 62%, which is much higher than the ratio of the current yield to the forward FCF yield.\nREITs\nFor a second screen of real estate investment trusts, we used funds from operations (FFO) instead of free cash flow. FFO adds depreciation on real estate to earnings and nets out gains or losses on the sale of property. Here are the 10 highest-yielding REITs in the S&P Composite 1500 with positive forward and trailing FFO \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet:\n\n\n\nREIT\nDividend yield\nForward FFO yield\nForward \"headroom\"\nTrailing FFO yield\nTrailing \"headroom\"\n\n\nOmega Healthcare Investors Inc. OHI\n7.27%\n9.08%\n1.81%\n8.93%\n1.65%\n\n\nLTC Properties Inc. LTC\n5.88%\n7.00%\n1.12%\n5.91%\n0.03%\n\n\nMedical Properties Trust Inc. MPW\n5.58%\n8.91%\n3.33%\n8.07%\n2.49%\n\n\nBrandywine Realty Trust BDN\n5.44%\n9.98%\n4.55%\n10.01%\n4.58%\n\n\nPhysicians Realty Trust DOC\n4.99%\n6.02%\n1.03%\n5.75%\n0.76%\n\n\nIndustrial Logistics Properties Trust\n4.97%\n7.10%\n2.14%\n7.00%\n2.03%\n\n\nGetty Realty Corp. GTY\n4.91%\n6.16%\n1.26%\n7.14%\n2.23%\n\n\nEasterly Government Properties Inc. DEA\n4.83%\n6.14%\n1.31%\n5.95%\n1.12%\n\n\nSL Green Realty Corp. SLG\n4.71%\n8.73%\n4.03%\n8.89%\n4.18%\n\n\nCareTrust REIT Inc. CTRE\n4.48%\n6.49%\n2.00%\n5.92%\n1.44%\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\nAs always, you should do your own research before considering any stock for investment. For the REITs, it is especially important to consider a company's investment focus. Whether it is retail, office property, health-care property or another area, each has its own opportunities and challenges.","news_type":1,"symbols_score_info":{"KMI":0.9,"T":0.9,"WMB":0.9,"ABBV":0.9,"CRCT":0.9,"TERN":0.9,"VZ":0.9}},"isVote":1,"tweetType":1,"viewCount":2093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147364986,"gmtCreate":1626336162845,"gmtModify":1703758129677,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147364986","repostId":"1170648442","repostType":4,"isVote":1,"tweetType":1,"viewCount":2134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143716081,"gmtCreate":1625817769043,"gmtModify":1703749143630,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Hope to build positions in outstanding Chinese companies during this time of uncertainty!","listText":"Hope to build positions in outstanding Chinese companies during this time of uncertainty!","text":"Hope to build positions in outstanding Chinese companies during this time of uncertainty!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143716081","repostId":"2150537804","repostType":4,"repost":{"id":"2150537804","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625817316,"share":"https://ttm.financial/m/news/2150537804?lang=en_US&edition=fundamental","pubTime":"2021-07-09 15:55","market":"sh","language":"en","title":"China stocks slip after inflation data","url":"https://stock-news.laohu8.com/highlight/detail?id=2150537804","media":"Reuters","summary":"Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annu","content":"<p>Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annual factory gate inflation remained uncomfortably high and underlined growing strains on the economy.</p>\n<p>Major indexes barely moved for the week as Beijing's surprise hint at monetary easing earlier this week failed to provide support and raised worries over the country's economic recovery.</p>\n<p>** The blue-chip CSI300 index fell 0.4% to 5,069.44, while the Shanghai Composite Index ended flat at 3,524.09.</p>\n<p>** The CSI300 shed 0.2% for the week, while SSEC gained 0.2%.</p>\n<p>** China's factory gate inflation eased in June, but the annual rate stayed high. The persistently high inflationary pressures in the industrial sector prompted China's cabinet this week to flag potential policy easing measures.</p>\n<p>** China's cabinet said on Wednesday it would use timely cuts in the bank reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> to support the real economy, especially small firms.</p>\n<p>** However, analysts said the hints did not point to a turnaround in monetary policy and added that it raised worries that the economic recovery was weaker than expected.</p>\n<p>** Investors should pay close attention to potential risks as the market now faces changes, including risks from some of China's real estate debts and the U.S. Fed's taper talk, Huaan Securities said in a note.</p>\n<p>** The brokerage recommended sectors with robust earnings growth in the first half, including semiconductor, new energy vehicles-related firms and sectors with low valuations.</p>\n<p>** Tech stocks shined this week, with Shanghai's STAR50 index posting its ninth week of gains.</p>\n<p>** Six of China's ministries, including the Ministry of Industry and Information Technology, pledged over the weekend to foster outstanding manufacturers and support qualified companies to get financing from capital markets.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip after inflation data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip after inflation data\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 15:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annual factory gate inflation remained uncomfortably high and underlined growing strains on the economy.</p>\n<p>Major indexes barely moved for the week as Beijing's surprise hint at monetary easing earlier this week failed to provide support and raised worries over the country's economic recovery.</p>\n<p>** The blue-chip CSI300 index fell 0.4% to 5,069.44, while the Shanghai Composite Index ended flat at 3,524.09.</p>\n<p>** The CSI300 shed 0.2% for the week, while SSEC gained 0.2%.</p>\n<p>** China's factory gate inflation eased in June, but the annual rate stayed high. The persistently high inflationary pressures in the industrial sector prompted China's cabinet this week to flag potential policy easing measures.</p>\n<p>** China's cabinet said on Wednesday it would use timely cuts in the bank reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> to support the real economy, especially small firms.</p>\n<p>** However, analysts said the hints did not point to a turnaround in monetary policy and added that it raised worries that the economic recovery was weaker than expected.</p>\n<p>** Investors should pay close attention to potential risks as the market now faces changes, including risks from some of China's real estate debts and the U.S. Fed's taper talk, Huaan Securities said in a note.</p>\n<p>** The brokerage recommended sectors with robust earnings growth in the first half, including semiconductor, new energy vehicles-related firms and sectors with low valuations.</p>\n<p>** Tech stocks shined this week, with Shanghai's STAR50 index posting its ninth week of gains.</p>\n<p>** Six of China's ministries, including the Ministry of Industry and Information Technology, pledged over the weekend to foster outstanding manufacturers and support qualified companies to get financing from capital markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150537804","content_text":"Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annual factory gate inflation remained uncomfortably high and underlined growing strains on the economy.\nMajor indexes barely moved for the week as Beijing's surprise hint at monetary easing earlier this week failed to provide support and raised worries over the country's economic recovery.\n** The blue-chip CSI300 index fell 0.4% to 5,069.44, while the Shanghai Composite Index ended flat at 3,524.09.\n** The CSI300 shed 0.2% for the week, while SSEC gained 0.2%.\n** China's factory gate inflation eased in June, but the annual rate stayed high. The persistently high inflationary pressures in the industrial sector prompted China's cabinet this week to flag potential policy easing measures.\n** China's cabinet said on Wednesday it would use timely cuts in the bank reserve requirement ratio $(RRR)$ to support the real economy, especially small firms.\n** However, analysts said the hints did not point to a turnaround in monetary policy and added that it raised worries that the economic recovery was weaker than expected.\n** Investors should pay close attention to potential risks as the market now faces changes, including risks from some of China's real estate debts and the U.S. Fed's taper talk, Huaan Securities said in a note.\n** The brokerage recommended sectors with robust earnings growth in the first half, including semiconductor, new energy vehicles-related firms and sectors with low valuations.\n** Tech stocks shined this week, with Shanghai's STAR50 index posting its ninth week of gains.\n** Six of China's ministries, including the Ministry of Industry and Information Technology, pledged over the weekend to foster outstanding manufacturers and support qualified companies to get financing from capital markets.","news_type":1,"symbols_score_info":{"000001.SH":0.9}},"isVote":1,"tweetType":1,"viewCount":3310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125221349,"gmtCreate":1624676137781,"gmtModify":1703843403423,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Love Tesla!","listText":"Love Tesla!","text":"Love Tesla!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/125221349","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":2819,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125239349,"gmtCreate":1624674180881,"gmtModify":1703843345376,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572785254205295","idStr":"3572785254205295"},"themes":[],"htmlText":"Hope to add to my portfolio","listText":"Hope to add to my portfolio","text":"Hope to add to my portfolio","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125239349","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":179200850,"gmtCreate":1626527180870,"gmtModify":1703761466070,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"To the moon!","listText":"To the moon!","text":"To the moon!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/179200850","repostId":"2152168594","repostType":4,"isVote":1,"tweetType":1,"viewCount":3061,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179209144,"gmtCreate":1626527261088,"gmtModify":1703761468662,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Buy the dip!","listText":"Buy the dip!","text":"Buy the dip!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/179209144","repostId":"1198202103","repostType":4,"isVote":1,"tweetType":1,"viewCount":3237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125221349,"gmtCreate":1624676137781,"gmtModify":1703843403423,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Love Tesla!","listText":"Love Tesla!","text":"Love Tesla!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/125221349","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":2819,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176021480,"gmtCreate":1626847335240,"gmtModify":1703479215908,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"This is great news","listText":"This is great news","text":"This is great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/176021480","repostId":"1196827638","repostType":4,"isVote":1,"tweetType":1,"viewCount":2798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173089819,"gmtCreate":1626585695831,"gmtModify":1703762080224,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Trust in Fauzi","listText":"Trust in Fauzi","text":"Trust in Fauzi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/173089819","repostId":"2152811496","repostType":4,"repost":{"id":"2152811496","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626548760,"share":"https://ttm.financial/m/news/2152811496?lang=en_US&edition=fundamental","pubTime":"2021-07-18 03:06","market":"us","language":"en","title":"Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?","url":"https://stock-news.laohu8.com/highlight/detail?id=2152811496","media":"Dow Jones","summary":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' s","content":"<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer is making the case for COVID-19 booster shots. Fauci say we don't need a third dose yet. Who's right?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-18 03:06</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert</p>\n<p>A very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.</p>\n<p>Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.</p>\n<p>Health officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.</p>\n<p>\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.</p>\n<p>Dr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.</p>\n<p>And, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.</p>\n<p>But if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.</p>\n<p>\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"</p>\n<p>The vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.</p>\n<p>\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.</p>\n<p>The case for boosters is complicated</p>\n<p>Many public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.</p>\n<p>Some experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.</p>\n<p>\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"</p>\n<p>This discussion is already playing out in other countries.</p>\n<p>A group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.</p>\n<p>In the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a>, Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a>, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.</p>\n<p>\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"</p>\n<p>Moderna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.</p>\n<p>Pfizer has not announced any deals that include boosters with the U.S.</p>\n<p>\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.</p>\n<p>How long does immunity from vaccines last?</p>\n<p>In a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.</p>\n<p>These include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?</p>\n<p>To further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.</p>\n<p>\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"</p>\n<p>Pfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> year of protection.</p>\n<p>\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"</p>\n<p>See now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","JNJ":"强生","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152811496","content_text":"'I think people are hesitant to support booster dosing because at least for now it's unnecessary,' said Dr. Paul Offit, a vaccine expert\nA very public regulatory debate about COVID-19 booster shots has seemingly put Pfizer at odds with federal health officials who say it's not necessary to get another shot at this time.\nPfizer $(PFE)$ last week reiterated plans to seek emergency authorization that tied waning protection from its vaccine to the more transmissible delta variant. The drug maker also said it's developing a booster specifically targeting delta, which is now thought to be the dominant strain of the virus in the U.S.\nHealth officials and medical experts, on the other hand, continue to say there is no scientific case for COVID-19 boosters right now.\n\"I think people are hesitant to support booster dosing because at least for now it's unnecessary,\" Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital of Philadelphia, told MarketWatch in an email.\nDr. Anthony Fauci, chief medical adviser to President Joe Biden, on Sunday told CNN on Thursday saying something similar.\nAnd, in an email sent Friday afternoon and viewed by MarketWatch, National Institutes of Health director Dr. Francis Collins told staff that \"Pfizer seems to have gotten way out over their skis here,\" indicating that the company may be getting ahead of itself when it comes to boosters.\nBut if the science evolves and it indicates that boosters are needed, that's going to present a new set of communication challenges for the Biden administration.\n\"It's distracting if people are getting an impression from statements from companies that they need\" to get a booster, said Dr. Lynn Goldman, an epidemiologist and dean of the Milken Institute School of Public Health at George Washington University. \"We're still trying to get people to immunize in the first place.\"\nThe vaccination rate in the U.S. has flatlined at 48% . Telling people they need to get a third shot down line could lead to confusion, frustration, or an even more firm \"no\" from the hesitant.\n\"When you have so many Americans that are hesitant to get vaccinated, articulating to them that, 'Hey, the initial vaccines aren't going to be enough forever, and you're going to have to do this on a regular occurrence,' could make them more skeptical of the vaccines and less willing to get vaccinated initially,\" said Chris Meekins, a health policy analyst at Raymond James.\nThe case for boosters is complicated\nMany public-health experts have said they expect booster doses will be necessary as immunity wanes and new variants emerge. However, much of that need is going to be based on when protection begins to diminish and in whom.\nSome experts believe booster shots will only be recommended for certain vulnerable segments of the population, like the elderly or people who are immunocompromised, and not for generally healthy Americans who want to reinforce the level of protection they already have. An influential CDC committee is expected to meet July 22 to discuss whether immunocompromised people need a booster shot.\n\"We believe the likely upcoming spike in cases and deaths may tip the balance\" in favor of boosters, RBC Capital Markets analyst Brian Abrahams told investors this week. \"Should a targeted booster approach be taken, we believe this provides evidence that immunosuppressed individuals and those with co-morbidities should be among the first dosed.\"\nThis discussion is already playing out in other countries.\nA group of French doctors published a letter , outlining who can get a third shot depending on age, health status, and profession. Israel is now offering third doses to the immunocompromised.\nIn the U.S., vaccine makers face a specific set of obstacles. One has to do with ensuring supply at a time when the authorized vaccines developed by Johnson & Johnson $(JNJ)$, Moderna $(MRNA)$, and Pfizer are still bound by the requirements of the Defense Production Act, which can require companies based here to give priority to the U.S. during the public-health emergency.\n\"It looks like the pharmaceutical company is at odds with our federal health officials,\" said Dr. Leana Wen, an emergency room physician, \"when, actually, this is a matter of the pharmaceutical companies wanting to be prepared, wanting to have the boosters available, if and when they're needed.\"\nModerna is studying booster doses, too. It announced a new deal in June with the U.S. for 200 million doses, \"which could be used for primary vaccination, including of children, or possibly as a booster if that becomes necessary to continue to defeat the pandemic,\" Moderna CEO Stéphane Bancel said in a news release. The company has signed agreements that could include booster shots with Argentina, Europe, Saudi Arabia, and Switzerland.\nPfizer has not announced any deals that include boosters with the U.S.\n\"I think the company believes that it can garner public opinion to support a booster over people's fear of the most recent delta variant and are capitalizing on that opportunity to try to force the government in the direction they want it to go,\" Meekins said.\nHow long does immunity from vaccines last?\nIn a nutshell: We don't know. There are a still a number of unanswered questions about the \"durability\" of immunity.\nThese include: What is the level of neutralizing antibody titers that still provide protection? Will T-cell response provide immunity if antibodies wane? When will we have a test that assesses antibody levels? When will the FDA establish a \"correlate\" of protection? Will only the most vulnerable people need a boost?\nTo further complicate things, this is the first time we've had a vaccine for a coronavirus and the first time that mRNA shots have ever been deployed. Those factors create additional unknowns. And so without answers to some or all of these questions, we are largely stuck guessing.\n\"We basically are operating, in my view, in a fact-free zone,\" Goldman said. \"I don't think it at all irrational to get a EUA for boosters right now. I see the rationale. How we talk about it is a different issue.\"\nPfizer recently said that immunity provided by its COVID-19 vaccine can wane six to 12 months after full vaccination; other officials believe the length of immunity is close to the tail end of that estimate, including the FDA's Dr. Peter Marks, who suggested in May that it's closer to at least one year of protection.\n\"It's very unlikely that immunity is just going to fall off a cliff at some point,\" Wen said. \"More likely, you're going to see a gradual waning over time...And so I think that is part of the difficulty in translating these complicated messages to sound bites for the general public.\"\nSee now:WHO head slams countries for ordering millions of COVID booster shots, when much of the world has not even vaccinated the most vulnerable","news_type":1,"symbols_score_info":{"JNJ":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2543,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800623804,"gmtCreate":1627299466508,"gmtModify":1703487060907,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Great advice!","listText":"Great advice!","text":"Great advice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/800623804","repostId":"2154454934","repostType":4,"isVote":1,"tweetType":1,"viewCount":2801,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":143716081,"gmtCreate":1625817769043,"gmtModify":1703749143630,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Hope to build positions in outstanding Chinese companies during this time of uncertainty!","listText":"Hope to build positions in outstanding Chinese companies during this time of uncertainty!","text":"Hope to build positions in outstanding Chinese companies during this time of uncertainty!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143716081","repostId":"2150537804","repostType":4,"repost":{"id":"2150537804","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625817316,"share":"https://ttm.financial/m/news/2150537804?lang=en_US&edition=fundamental","pubTime":"2021-07-09 15:55","market":"sh","language":"en","title":"China stocks slip after inflation data","url":"https://stock-news.laohu8.com/highlight/detail?id=2150537804","media":"Reuters","summary":"Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annu","content":"<p>Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annual factory gate inflation remained uncomfortably high and underlined growing strains on the economy.</p>\n<p>Major indexes barely moved for the week as Beijing's surprise hint at monetary easing earlier this week failed to provide support and raised worries over the country's economic recovery.</p>\n<p>** The blue-chip CSI300 index fell 0.4% to 5,069.44, while the Shanghai Composite Index ended flat at 3,524.09.</p>\n<p>** The CSI300 shed 0.2% for the week, while SSEC gained 0.2%.</p>\n<p>** China's factory gate inflation eased in June, but the annual rate stayed high. The persistently high inflationary pressures in the industrial sector prompted China's cabinet this week to flag potential policy easing measures.</p>\n<p>** China's cabinet said on Wednesday it would use timely cuts in the bank reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> to support the real economy, especially small firms.</p>\n<p>** However, analysts said the hints did not point to a turnaround in monetary policy and added that it raised worries that the economic recovery was weaker than expected.</p>\n<p>** Investors should pay close attention to potential risks as the market now faces changes, including risks from some of China's real estate debts and the U.S. Fed's taper talk, Huaan Securities said in a note.</p>\n<p>** The brokerage recommended sectors with robust earnings growth in the first half, including semiconductor, new energy vehicles-related firms and sectors with low valuations.</p>\n<p>** Tech stocks shined this week, with Shanghai's STAR50 index posting its ninth week of gains.</p>\n<p>** Six of China's ministries, including the Ministry of Industry and Information Technology, pledged over the weekend to foster outstanding manufacturers and support qualified companies to get financing from capital markets.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks slip after inflation data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks slip after inflation data\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 15:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annual factory gate inflation remained uncomfortably high and underlined growing strains on the economy.</p>\n<p>Major indexes barely moved for the week as Beijing's surprise hint at monetary easing earlier this week failed to provide support and raised worries over the country's economic recovery.</p>\n<p>** The blue-chip CSI300 index fell 0.4% to 5,069.44, while the Shanghai Composite Index ended flat at 3,524.09.</p>\n<p>** The CSI300 shed 0.2% for the week, while SSEC gained 0.2%.</p>\n<p>** China's factory gate inflation eased in June, but the annual rate stayed high. The persistently high inflationary pressures in the industrial sector prompted China's cabinet this week to flag potential policy easing measures.</p>\n<p>** China's cabinet said on Wednesday it would use timely cuts in the bank reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> to support the real economy, especially small firms.</p>\n<p>** However, analysts said the hints did not point to a turnaround in monetary policy and added that it raised worries that the economic recovery was weaker than expected.</p>\n<p>** Investors should pay close attention to potential risks as the market now faces changes, including risks from some of China's real estate debts and the U.S. Fed's taper talk, Huaan Securities said in a note.</p>\n<p>** The brokerage recommended sectors with robust earnings growth in the first half, including semiconductor, new energy vehicles-related firms and sectors with low valuations.</p>\n<p>** Tech stocks shined this week, with Shanghai's STAR50 index posting its ninth week of gains.</p>\n<p>** Six of China's ministries, including the Ministry of Industry and Information Technology, pledged over the weekend to foster outstanding manufacturers and support qualified companies to get financing from capital markets.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150537804","content_text":"Shanghai, July 9 (Reuters) - China stocks edged lower on Friday after data showed the country's annual factory gate inflation remained uncomfortably high and underlined growing strains on the economy.\nMajor indexes barely moved for the week as Beijing's surprise hint at monetary easing earlier this week failed to provide support and raised worries over the country's economic recovery.\n** The blue-chip CSI300 index fell 0.4% to 5,069.44, while the Shanghai Composite Index ended flat at 3,524.09.\n** The CSI300 shed 0.2% for the week, while SSEC gained 0.2%.\n** China's factory gate inflation eased in June, but the annual rate stayed high. The persistently high inflationary pressures in the industrial sector prompted China's cabinet this week to flag potential policy easing measures.\n** China's cabinet said on Wednesday it would use timely cuts in the bank reserve requirement ratio $(RRR)$ to support the real economy, especially small firms.\n** However, analysts said the hints did not point to a turnaround in monetary policy and added that it raised worries that the economic recovery was weaker than expected.\n** Investors should pay close attention to potential risks as the market now faces changes, including risks from some of China's real estate debts and the U.S. Fed's taper talk, Huaan Securities said in a note.\n** The brokerage recommended sectors with robust earnings growth in the first half, including semiconductor, new energy vehicles-related firms and sectors with low valuations.\n** Tech stocks shined this week, with Shanghai's STAR50 index posting its ninth week of gains.\n** Six of China's ministries, including the Ministry of Industry and Information Technology, pledged over the weekend to foster outstanding manufacturers and support qualified companies to get financing from capital markets.","news_type":1,"symbols_score_info":{"000001.SH":0.9}},"isVote":1,"tweetType":1,"viewCount":3310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125239349,"gmtCreate":1624674180881,"gmtModify":1703843345376,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Hope to add to my portfolio","listText":"Hope to add to my portfolio","text":"Hope to add to my portfolio","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125239349","repostId":"1100072036","repostType":4,"isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171476592,"gmtCreate":1626760697416,"gmtModify":1703764689501,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Up, up and away!","listText":"Up, up and away!","text":"Up, up and away!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171476592","repostId":"1101815579","repostType":4,"repost":{"id":"1101815579","kind":"news","pubTimestamp":1626757956,"share":"https://ttm.financial/m/news/1101815579?lang=en_US&edition=fundamental","pubTime":"2021-07-20 13:12","market":"hk","language":"en","title":"Gold Up, Boosted by Ongoing COVID-19 Worries","url":"https://stock-news.laohu8.com/highlight/detail?id=1101815579","media":"investing.com","summary":"Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreak","content":"<p>Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreaks involving the Delta variant in several countries also gave the safe-haven yellow metal a boost.</p>\n<p>Gold futures&nbsp;were up 0.51% to $1,818.50 by 1:05 PM ET (5:05 AM GMT) after falling to a one-week low of $1,794.06 during the previous session.</p>\n<p>The&nbsp;dollar, which normally moves inversely to gold, inched down on Tuesday but remained near a three-and-a-half-month peak. Benchmark 10-year U.S. Treasury yields fell to near five-month lows.</p>\n<p>In Asia, the&nbsp;People's Bank of China&nbsp;also kept its July loan prime rate&nbsp;(LPR) unchanged for the fifteenth straight month, with the one-year LPR at 3.85% and the five-year LPR at 4.65%. The European Central Bank and Bank Indonesia will also hand down their respective policy decision on Thursday.</p>\n<p>Japan’s&nbsp;national core consumer price index (CPI)&nbsp;grew 0.2% year-on-year in June, the fastest annual pace in over a year, according to data released earlier in the day. The data also saidnational CPIgrowth remained unchanged at 0.3% month-on-month.</p>\n<p>On the stimulus front, U.S. Senate Democratic leader Chuck Schumer said on Monday that he would set a procedural vote on a bipartisan, $1.2 trillion infrastructure bill for Wednesday.</p>\n<p>In other precious metals, silver eased 0.1%, palladium was steady at $2,597.23, and platinum rose 0.3% to $1,077.98.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold Up, Boosted by Ongoing COVID-19 Worries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold Up, Boosted by Ongoing COVID-19 Worries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 13:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investing.com/news/commodities-news/gold-up-boosted-by-ongoing-covid19-worries-2562304><strong>investing.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreaks involving the Delta variant in several countries also gave the safe-haven yellow metal a boost.\n...</p>\n\n<a href=\"https://www.investing.com/news/commodities-news/gold-up-boosted-by-ongoing-covid19-worries-2562304\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.investing.com/news/commodities-news/gold-up-boosted-by-ongoing-covid19-worries-2562304","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101815579","content_text":"Investing.com – Gold was up on Tuesday morning in Asia as concerns over the recent COVID-19 outbreaks involving the Delta variant in several countries also gave the safe-haven yellow metal a boost.\nGold futures were up 0.51% to $1,818.50 by 1:05 PM ET (5:05 AM GMT) after falling to a one-week low of $1,794.06 during the previous session.\nThe dollar, which normally moves inversely to gold, inched down on Tuesday but remained near a three-and-a-half-month peak. Benchmark 10-year U.S. Treasury yields fell to near five-month lows.\nIn Asia, the People's Bank of China also kept its July loan prime rate (LPR) unchanged for the fifteenth straight month, with the one-year LPR at 3.85% and the five-year LPR at 4.65%. The European Central Bank and Bank Indonesia will also hand down their respective policy decision on Thursday.\nJapan’s national core consumer price index (CPI) grew 0.2% year-on-year in June, the fastest annual pace in over a year, according to data released earlier in the day. The data also saidnational CPIgrowth remained unchanged at 0.3% month-on-month.\nOn the stimulus front, U.S. Senate Democratic leader Chuck Schumer said on Monday that he would set a procedural vote on a bipartisan, $1.2 trillion infrastructure bill for Wednesday.\nIn other precious metals, silver eased 0.1%, palladium was steady at $2,597.23, and platinum rose 0.3% to $1,077.98.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":2150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147364986,"gmtCreate":1626336162845,"gmtModify":1703758129677,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147364986","repostId":"1170648442","repostType":4,"isVote":1,"tweetType":1,"viewCount":2134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147320439,"gmtCreate":1626336289021,"gmtModify":1703758133101,"author":{"id":"3572785254205295","authorId":"3572785254205295","name":"SidneyYee","avatar":"https://static.tigerbbs.com/265c089d41e4955b702b04997fe8a924","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572785254205295","authorIdStr":"3572785254205295"},"themes":[],"htmlText":"How are the taxes on dividend income handled with tiger brokers?","listText":"How are the taxes on dividend income handled with tiger brokers?","text":"How are the taxes on dividend income handled with tiger brokers?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147320439","repostId":"2151751740","repostType":4,"repost":{"id":"2151751740","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626280020,"share":"https://ttm.financial/m/news/2151751740?lang=en_US&edition=fundamental","pubTime":"2021-07-15 00:27","market":"hk","language":"en","title":"19 dividend stocks to help you combat inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=2151751740","media":"Dow Jones","summary":"These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S","content":"<blockquote>\n These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S. Treasury notes.\n</blockquote>\n<p>How can you avoid inflation, or at least make up for it?</p>\n<p>Consumers and investors may be alarmed by rising prices. But a combination of prudent spending and investing can help these overlapping groups of people get through a period of uncertainty brought about by pent-up demand and supply shortages.</p>\n<p>Below are two lists of 19 dividend stocks with attractive yields -- companies that are expected to have plenty of cash flow to cover dividend increases or other actions that may be good for shareholders, including stock repurchases and business expansion.</p>\n<p>The consumer price index rose by 0.9% in only <a href=\"https://laohu8.com/S/AONE\">one</a> month . It's easy to say that you shouldn't buy a car or truck this year. The incredible demand for used vehicles has led to a shortage for many of the most popular new ones, which means dealers will be less likely to haggle.</p>\n<p>Of course you might be in a pickle and need to get another car or truck at the worst time, but maybe you can make a modest selection this time. You might also delay a plan to sell your home and move into a bigger <a href=\"https://laohu8.com/S/AONE.U\">one</a>, considering that every other national housing boom you have ever witnessed has eventually cooled. In other words, it is possible some of your big spending plans can be curbed or delayed.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> dividend stock screens</p>\n<p>What do you want from a dividend stock? The most obvious answer is \"income,\" but what may be more important is that the dividend increases over time. That's how you stay ahead of inflation. Even when official inflation figures are low, your personal inflation can be considerable, depending on your circumstances. Or you may need investment income to replace part of your working income when you retire.</p>\n<p>Here's a recent list of the 30 stocks in the S&amp;P 500 index whose dividends increased the most over the past five years . Their dividend yields may not have been very high to begin with, but if you had held them for five years, the yields on your five-year-old shares would have grown significantly.</p>\n<p>For this new screen, we took a different approach to focus more on higher current dividend yields. Beginning with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P Mid Cap 400 Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index ), we started with stocks with dividend yields of at least 4.26% -- three times the 1.42% yield on 10-year U.S. Treasury notes on July 13.</p>\n<p>Then we looked at free cash flow yields. A company's free cash flow is its remaining cash flow after planned capital expenditures. It can be used to increase dividends, buy back stock, pay down debt, business expansion or fund acquisitions. A free cash flow yield that is higher than the dividend yield can provide investors with some comfort that a company is unlikely to cut its dividend and maybe be in a position to increase it.</p>\n<p>A trailing free cash flow yield can be calculated by dividing the past four quarters' free cash flow per share by the current share price. If available, consensus estimates for the next 12 months can be used to calculate a forward FCF yield. If the FCF yield is above the current dividend yield, there is free cash flow \"headroom.\" (The screen below only includes companies for which forward FCF estimates were available from FactSet.)</p>\n<p>Financial companies were excluded from the screen, as FCF yield analysis isn't appropriate for the group. Companies with fewer than five analysts polled for FactSet's estimates were also excluded. For real estate investment trusts, funds from operations (FFO) is the industry standard for gauging dividend-paying ability. So there is a separate screen for that group below.</p>\n<p>Starting with the S&amp;P Composite 1500, here are the eight stocks that made the cut, with dividend yields of at least 4.26%, positive forward and trailing FCF \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet. The list is sorted by dividend yield:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Dividend yield</td>\n   <td>Forward FCF yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FCF yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td>Williams Cos. Inc. WMB</td>\n   <td>6.26%</td>\n   <td>9.08%</td>\n   <td>2.82%</td>\n   <td>7.53%</td>\n   <td>1.27%</td>\n  </tr>\n  <tr>\n   <td>B&amp;G Foods Inc. BGS</td>\n   <td>6.20%</td>\n   <td>11.44%</td>\n   <td>5.24%</td>\n   <td>11.00%</td>\n   <td>4.80%</td>\n  </tr>\n  <tr>\n   <td>Kinder Morgan Inc. Class P KMI</td>\n   <td>5.91%</td>\n   <td>9.86%</td>\n   <td>3.95%</td>\n   <td>9.98%</td>\n   <td>4.07%</td>\n  </tr>\n  <tr>\n   <td>H&amp;R Block Inc. HRB</td>\n   <td>4.57%</td>\n   <td>14.83%</td>\n   <td>10.25%</td>\n   <td>13.28%</td>\n   <td>8.71%</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications Inc. VZ</td>\n   <td>4.47%</td>\n   <td>7.84%</td>\n   <td>3.37%</td>\n   <td>10.86%</td>\n   <td>6.38%</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>4.47%</td>\n   <td>9.66%</td>\n   <td>5.19%</td>\n   <td>7.64%</td>\n   <td>3.18%</td>\n  </tr>\n  <tr>\n   <td>LyondellBasell Industries NV LYB</td>\n   <td>4.43%</td>\n   <td>10.82%</td>\n   <td>6.39%</td>\n   <td>5.30%</td>\n   <td>0.87%</td>\n  </tr>\n  <tr>\n   <td>AbbVie Inc. ABBV</td>\n   <td>4.41%</td>\n   <td>10.19%</td>\n   <td>5.77%</td>\n   <td>8.61%</td>\n   <td>4.20%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Click on the tickers for more about each company, including news, business profiles, price ratios and ratings.</p>\n<p>In case you are wondering about AT&amp;T Inc. <a href=\"https://laohu8.com/S/T\">$(T)$</a> -- known for its high dividend yield over the long term -- the company hasn't yet announced a dividend cut but said in March that as part of its plan to divest its WarnerMedia properties, it was going to \"resize \" the dividend, taking it down to a payout ratio of about 40% to 43% of free cash flow.</p>\n<p>We don't have the figures to predict how high the slimmed-down company's dividend might be after AT&amp;T's deals are completed, but the yield on the shares as of the close on July 13 was 7.36%, while its forward FCF yield was 11.79%. Ordinarily that would appear to be plenty of headroom to support the dividend. But it implies a payout ratio of 62%, which is much higher than the ratio of the current yield to the forward FCF yield.</p>\n<p>REITs</p>\n<p>For a second screen of real estate investment trusts, we used funds from operations (FFO) instead of free cash flow. FFO adds depreciation on real estate to earnings and nets out gains or losses on the sale of property. Here are the 10 highest-yielding REITs in the S&amp;P Composite 1500 with positive forward and trailing FFO \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet:</p>\n<table>\n <tbody>\n  <tr>\n   <td>REIT</td>\n   <td>Dividend yield</td>\n   <td>Forward FFO yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FFO yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/OHI\">Omega Healthcare Investors</a> Inc. OHI</td>\n   <td>7.27%</td>\n   <td>9.08%</td>\n   <td>1.81%</td>\n   <td>8.93%</td>\n   <td>1.65%</td>\n  </tr>\n  <tr>\n   <td>LTC Properties Inc. LTC</td>\n   <td>5.88%</td>\n   <td>7.00%</td>\n   <td>1.12%</td>\n   <td>5.91%</td>\n   <td>0.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MPW\">Medical Properties Trust</a> Inc. MPW</td>\n   <td>5.58%</td>\n   <td>8.91%</td>\n   <td>3.33%</td>\n   <td>8.07%</td>\n   <td>2.49%</td>\n  </tr>\n  <tr>\n   <td>Brandywine Realty Trust BDN</td>\n   <td>5.44%</td>\n   <td>9.98%</td>\n   <td>4.55%</td>\n   <td>10.01%</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DOC\">Physicians Realty Trust</a> DOC</td>\n   <td>4.99%</td>\n   <td>6.02%</td>\n   <td>1.03%</td>\n   <td>5.75%</td>\n   <td>0.76%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ILPT\">Industrial Logistics Properties Trust</a></td>\n   <td>4.97%</td>\n   <td>7.10%</td>\n   <td>2.14%</td>\n   <td>7.00%</td>\n   <td>2.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GTY\">Getty Realty Corp</a>. GTY</td>\n   <td>4.91%</td>\n   <td>6.16%</td>\n   <td>1.26%</td>\n   <td>7.14%</td>\n   <td>2.23%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DEA\">Easterly Government Properties Inc</a>. DEA</td>\n   <td>4.83%</td>\n   <td>6.14%</td>\n   <td>1.31%</td>\n   <td>5.95%</td>\n   <td>1.12%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SLG\">SL Green Realty Corp</a>. SLG</td>\n   <td>4.71%</td>\n   <td>8.73%</td>\n   <td>4.03%</td>\n   <td>8.89%</td>\n   <td>4.18%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/CTRE\">CareTrust REIT Inc.</a> CTRE</td>\n   <td>4.48%</td>\n   <td>6.49%</td>\n   <td>2.00%</td>\n   <td>5.92%</td>\n   <td>1.44%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>As always, you should do your own research before considering any stock for investment. For the REITs, it is especially important to consider a company's investment focus. Whether it is retail, office property, health-care property or another area, each has its own opportunities and challenges.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>19 dividend stocks to help you combat inflation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n19 dividend stocks to help you combat inflation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-15 00:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S. Treasury notes.\n</blockquote>\n<p>How can you avoid inflation, or at least make up for it?</p>\n<p>Consumers and investors may be alarmed by rising prices. But a combination of prudent spending and investing can help these overlapping groups of people get through a period of uncertainty brought about by pent-up demand and supply shortages.</p>\n<p>Below are two lists of 19 dividend stocks with attractive yields -- companies that are expected to have plenty of cash flow to cover dividend increases or other actions that may be good for shareholders, including stock repurchases and business expansion.</p>\n<p>The consumer price index rose by 0.9% in only <a href=\"https://laohu8.com/S/AONE\">one</a> month . It's easy to say that you shouldn't buy a car or truck this year. The incredible demand for used vehicles has led to a shortage for many of the most popular new ones, which means dealers will be less likely to haggle.</p>\n<p>Of course you might be in a pickle and need to get another car or truck at the worst time, but maybe you can make a modest selection this time. You might also delay a plan to sell your home and move into a bigger <a href=\"https://laohu8.com/S/AONE.U\">one</a>, considering that every other national housing boom you have ever witnessed has eventually cooled. In other words, it is possible some of your big spending plans can be curbed or delayed.</p>\n<p><a href=\"https://laohu8.com/S/TWOA.U\">Two</a> dividend stock screens</p>\n<p>What do you want from a dividend stock? The most obvious answer is \"income,\" but what may be more important is that the dividend increases over time. That's how you stay ahead of inflation. Even when official inflation figures are low, your personal inflation can be considerable, depending on your circumstances. Or you may need investment income to replace part of your working income when you retire.</p>\n<p>Here's a recent list of the 30 stocks in the S&amp;P 500 index whose dividends increased the most over the past five years . Their dividend yields may not have been very high to begin with, but if you had held them for five years, the yields on your five-year-old shares would have grown significantly.</p>\n<p>For this new screen, we took a different approach to focus more on higher current dividend yields. Beginning with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P Mid Cap 400 Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small Cap 600 Index ), we started with stocks with dividend yields of at least 4.26% -- three times the 1.42% yield on 10-year U.S. Treasury notes on July 13.</p>\n<p>Then we looked at free cash flow yields. A company's free cash flow is its remaining cash flow after planned capital expenditures. It can be used to increase dividends, buy back stock, pay down debt, business expansion or fund acquisitions. A free cash flow yield that is higher than the dividend yield can provide investors with some comfort that a company is unlikely to cut its dividend and maybe be in a position to increase it.</p>\n<p>A trailing free cash flow yield can be calculated by dividing the past four quarters' free cash flow per share by the current share price. If available, consensus estimates for the next 12 months can be used to calculate a forward FCF yield. If the FCF yield is above the current dividend yield, there is free cash flow \"headroom.\" (The screen below only includes companies for which forward FCF estimates were available from FactSet.)</p>\n<p>Financial companies were excluded from the screen, as FCF yield analysis isn't appropriate for the group. Companies with fewer than five analysts polled for FactSet's estimates were also excluded. For real estate investment trusts, funds from operations (FFO) is the industry standard for gauging dividend-paying ability. So there is a separate screen for that group below.</p>\n<p>Starting with the S&amp;P Composite 1500, here are the eight stocks that made the cut, with dividend yields of at least 4.26%, positive forward and trailing FCF \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet. The list is sorted by dividend yield:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Dividend yield</td>\n   <td>Forward FCF yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FCF yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td>Williams Cos. Inc. WMB</td>\n   <td>6.26%</td>\n   <td>9.08%</td>\n   <td>2.82%</td>\n   <td>7.53%</td>\n   <td>1.27%</td>\n  </tr>\n  <tr>\n   <td>B&amp;G Foods Inc. BGS</td>\n   <td>6.20%</td>\n   <td>11.44%</td>\n   <td>5.24%</td>\n   <td>11.00%</td>\n   <td>4.80%</td>\n  </tr>\n  <tr>\n   <td>Kinder Morgan Inc. Class P KMI</td>\n   <td>5.91%</td>\n   <td>9.86%</td>\n   <td>3.95%</td>\n   <td>9.98%</td>\n   <td>4.07%</td>\n  </tr>\n  <tr>\n   <td>H&amp;R Block Inc. HRB</td>\n   <td>4.57%</td>\n   <td>14.83%</td>\n   <td>10.25%</td>\n   <td>13.28%</td>\n   <td>8.71%</td>\n  </tr>\n  <tr>\n   <td>Verizon Communications Inc. VZ</td>\n   <td>4.47%</td>\n   <td>7.84%</td>\n   <td>3.37%</td>\n   <td>10.86%</td>\n   <td>6.38%</td>\n  </tr>\n  <tr>\n   <td>Dow Inc. DOW</td>\n   <td>4.47%</td>\n   <td>9.66%</td>\n   <td>5.19%</td>\n   <td>7.64%</td>\n   <td>3.18%</td>\n  </tr>\n  <tr>\n   <td>LyondellBasell Industries NV LYB</td>\n   <td>4.43%</td>\n   <td>10.82%</td>\n   <td>6.39%</td>\n   <td>5.30%</td>\n   <td>0.87%</td>\n  </tr>\n  <tr>\n   <td>AbbVie Inc. ABBV</td>\n   <td>4.41%</td>\n   <td>10.19%</td>\n   <td>5.77%</td>\n   <td>8.61%</td>\n   <td>4.20%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>Click on the tickers for more about each company, including news, business profiles, price ratios and ratings.</p>\n<p>In case you are wondering about AT&amp;T Inc. <a href=\"https://laohu8.com/S/T\">$(T)$</a> -- known for its high dividend yield over the long term -- the company hasn't yet announced a dividend cut but said in March that as part of its plan to divest its WarnerMedia properties, it was going to \"resize \" the dividend, taking it down to a payout ratio of about 40% to 43% of free cash flow.</p>\n<p>We don't have the figures to predict how high the slimmed-down company's dividend might be after AT&amp;T's deals are completed, but the yield on the shares as of the close on July 13 was 7.36%, while its forward FCF yield was 11.79%. Ordinarily that would appear to be plenty of headroom to support the dividend. But it implies a payout ratio of 62%, which is much higher than the ratio of the current yield to the forward FCF yield.</p>\n<p>REITs</p>\n<p>For a second screen of real estate investment trusts, we used funds from operations (FFO) instead of free cash flow. FFO adds depreciation on real estate to earnings and nets out gains or losses on the sale of property. Here are the 10 highest-yielding REITs in the S&amp;P Composite 1500 with positive forward and trailing FFO \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet:</p>\n<table>\n <tbody>\n  <tr>\n   <td>REIT</td>\n   <td>Dividend yield</td>\n   <td>Forward FFO yield</td>\n   <td>Forward \"headroom\"</td>\n   <td>Trailing FFO yield</td>\n   <td>Trailing \"headroom\"</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/OHI\">Omega Healthcare Investors</a> Inc. OHI</td>\n   <td>7.27%</td>\n   <td>9.08%</td>\n   <td>1.81%</td>\n   <td>8.93%</td>\n   <td>1.65%</td>\n  </tr>\n  <tr>\n   <td>LTC Properties Inc. LTC</td>\n   <td>5.88%</td>\n   <td>7.00%</td>\n   <td>1.12%</td>\n   <td>5.91%</td>\n   <td>0.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MPW\">Medical Properties Trust</a> Inc. MPW</td>\n   <td>5.58%</td>\n   <td>8.91%</td>\n   <td>3.33%</td>\n   <td>8.07%</td>\n   <td>2.49%</td>\n  </tr>\n  <tr>\n   <td>Brandywine Realty Trust BDN</td>\n   <td>5.44%</td>\n   <td>9.98%</td>\n   <td>4.55%</td>\n   <td>10.01%</td>\n   <td>4.58%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DOC\">Physicians Realty Trust</a> DOC</td>\n   <td>4.99%</td>\n   <td>6.02%</td>\n   <td>1.03%</td>\n   <td>5.75%</td>\n   <td>0.76%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ILPT\">Industrial Logistics Properties Trust</a></td>\n   <td>4.97%</td>\n   <td>7.10%</td>\n   <td>2.14%</td>\n   <td>7.00%</td>\n   <td>2.03%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GTY\">Getty Realty Corp</a>. GTY</td>\n   <td>4.91%</td>\n   <td>6.16%</td>\n   <td>1.26%</td>\n   <td>7.14%</td>\n   <td>2.23%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/DEA\">Easterly Government Properties Inc</a>. DEA</td>\n   <td>4.83%</td>\n   <td>6.14%</td>\n   <td>1.31%</td>\n   <td>5.95%</td>\n   <td>1.12%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/SLG\">SL Green Realty Corp</a>. SLG</td>\n   <td>4.71%</td>\n   <td>8.73%</td>\n   <td>4.03%</td>\n   <td>8.89%</td>\n   <td>4.18%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/CTRE\">CareTrust REIT Inc.</a> CTRE</td>\n   <td>4.48%</td>\n   <td>6.49%</td>\n   <td>2.00%</td>\n   <td>5.92%</td>\n   <td>1.44%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>As always, you should do your own research before considering any stock for investment. For the REITs, it is especially important to consider a company's investment focus. Whether it is retail, office property, health-care property or another area, each has its own opportunities and challenges.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KMI":"金德尔摩根","T":"At&T","ABBV":"艾伯维公司","WMB":"威廉姆斯","VZ":"Verizon Comms","TERN":"Terns Pharmaceuticals, Inc.","CRCT":"Cricut, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151751740","content_text":"These stocks have dividend yields that are at least three times as high as the yields on 10-year U.S. Treasury notes.\n\nHow can you avoid inflation, or at least make up for it?\nConsumers and investors may be alarmed by rising prices. But a combination of prudent spending and investing can help these overlapping groups of people get through a period of uncertainty brought about by pent-up demand and supply shortages.\nBelow are two lists of 19 dividend stocks with attractive yields -- companies that are expected to have plenty of cash flow to cover dividend increases or other actions that may be good for shareholders, including stock repurchases and business expansion.\nThe consumer price index rose by 0.9% in only one month . It's easy to say that you shouldn't buy a car or truck this year. The incredible demand for used vehicles has led to a shortage for many of the most popular new ones, which means dealers will be less likely to haggle.\nOf course you might be in a pickle and need to get another car or truck at the worst time, but maybe you can make a modest selection this time. You might also delay a plan to sell your home and move into a bigger one, considering that every other national housing boom you have ever witnessed has eventually cooled. In other words, it is possible some of your big spending plans can be curbed or delayed.\nTwo dividend stock screens\nWhat do you want from a dividend stock? The most obvious answer is \"income,\" but what may be more important is that the dividend increases over time. That's how you stay ahead of inflation. Even when official inflation figures are low, your personal inflation can be considerable, depending on your circumstances. Or you may need investment income to replace part of your working income when you retire.\nHere's a recent list of the 30 stocks in the S&P 500 index whose dividends increased the most over the past five years . Their dividend yields may not have been very high to begin with, but if you had held them for five years, the yields on your five-year-old shares would have grown significantly.\nFor this new screen, we took a different approach to focus more on higher current dividend yields. Beginning with the S&P Composite 1500 Index (made up of the S&P 500 , the S&P Mid Cap 400 Index $(MID)$ and the S&P Small Cap 600 Index ), we started with stocks with dividend yields of at least 4.26% -- three times the 1.42% yield on 10-year U.S. Treasury notes on July 13.\nThen we looked at free cash flow yields. A company's free cash flow is its remaining cash flow after planned capital expenditures. It can be used to increase dividends, buy back stock, pay down debt, business expansion or fund acquisitions. A free cash flow yield that is higher than the dividend yield can provide investors with some comfort that a company is unlikely to cut its dividend and maybe be in a position to increase it.\nA trailing free cash flow yield can be calculated by dividing the past four quarters' free cash flow per share by the current share price. If available, consensus estimates for the next 12 months can be used to calculate a forward FCF yield. If the FCF yield is above the current dividend yield, there is free cash flow \"headroom.\" (The screen below only includes companies for which forward FCF estimates were available from FactSet.)\nFinancial companies were excluded from the screen, as FCF yield analysis isn't appropriate for the group. Companies with fewer than five analysts polled for FactSet's estimates were also excluded. For real estate investment trusts, funds from operations (FFO) is the industry standard for gauging dividend-paying ability. So there is a separate screen for that group below.\nStarting with the S&P Composite 1500, here are the eight stocks that made the cut, with dividend yields of at least 4.26%, positive forward and trailing FCF \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet. The list is sorted by dividend yield:\n\n\n\nCompany\nDividend yield\nForward FCF yield\nForward \"headroom\"\nTrailing FCF yield\nTrailing \"headroom\"\n\n\nWilliams Cos. Inc. WMB\n6.26%\n9.08%\n2.82%\n7.53%\n1.27%\n\n\nB&G Foods Inc. BGS\n6.20%\n11.44%\n5.24%\n11.00%\n4.80%\n\n\nKinder Morgan Inc. Class P KMI\n5.91%\n9.86%\n3.95%\n9.98%\n4.07%\n\n\nH&R Block Inc. HRB\n4.57%\n14.83%\n10.25%\n13.28%\n8.71%\n\n\nVerizon Communications Inc. VZ\n4.47%\n7.84%\n3.37%\n10.86%\n6.38%\n\n\nDow Inc. DOW\n4.47%\n9.66%\n5.19%\n7.64%\n3.18%\n\n\nLyondellBasell Industries NV LYB\n4.43%\n10.82%\n6.39%\n5.30%\n0.87%\n\n\nAbbVie Inc. ABBV\n4.41%\n10.19%\n5.77%\n8.61%\n4.20%\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\nClick on the tickers for more about each company, including news, business profiles, price ratios and ratings.\nIn case you are wondering about AT&T Inc. $(T)$ -- known for its high dividend yield over the long term -- the company hasn't yet announced a dividend cut but said in March that as part of its plan to divest its WarnerMedia properties, it was going to \"resize \" the dividend, taking it down to a payout ratio of about 40% to 43% of free cash flow.\nWe don't have the figures to predict how high the slimmed-down company's dividend might be after AT&T's deals are completed, but the yield on the shares as of the close on July 13 was 7.36%, while its forward FCF yield was 11.79%. Ordinarily that would appear to be plenty of headroom to support the dividend. But it implies a payout ratio of 62%, which is much higher than the ratio of the current yield to the forward FCF yield.\nREITs\nFor a second screen of real estate investment trusts, we used funds from operations (FFO) instead of free cash flow. FFO adds depreciation on real estate to earnings and nets out gains or losses on the sale of property. Here are the 10 highest-yielding REITs in the S&P Composite 1500 with positive forward and trailing FFO \"headroom\" and no dividend cuts over the past three years, according to data provided by FactSet:\n\n\n\nREIT\nDividend yield\nForward FFO yield\nForward \"headroom\"\nTrailing FFO yield\nTrailing \"headroom\"\n\n\nOmega Healthcare Investors Inc. OHI\n7.27%\n9.08%\n1.81%\n8.93%\n1.65%\n\n\nLTC Properties Inc. LTC\n5.88%\n7.00%\n1.12%\n5.91%\n0.03%\n\n\nMedical Properties Trust Inc. MPW\n5.58%\n8.91%\n3.33%\n8.07%\n2.49%\n\n\nBrandywine Realty Trust BDN\n5.44%\n9.98%\n4.55%\n10.01%\n4.58%\n\n\nPhysicians Realty Trust DOC\n4.99%\n6.02%\n1.03%\n5.75%\n0.76%\n\n\nIndustrial Logistics Properties Trust\n4.97%\n7.10%\n2.14%\n7.00%\n2.03%\n\n\nGetty Realty Corp. GTY\n4.91%\n6.16%\n1.26%\n7.14%\n2.23%\n\n\nEasterly Government Properties Inc. DEA\n4.83%\n6.14%\n1.31%\n5.95%\n1.12%\n\n\nSL Green Realty Corp. SLG\n4.71%\n8.73%\n4.03%\n8.89%\n4.18%\n\n\nCareTrust REIT Inc. CTRE\n4.48%\n6.49%\n2.00%\n5.92%\n1.44%\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\nAs always, you should do your own research before considering any stock for investment. For the REITs, it is especially important to consider a company's investment focus. Whether it is retail, office property, health-care property or another area, each has its own opportunities and challenges.","news_type":1,"symbols_score_info":{"KMI":0.9,"T":0.9,"WMB":0.9,"ABBV":0.9,"CRCT":0.9,"TERN":0.9,"VZ":0.9}},"isVote":1,"tweetType":1,"viewCount":2093,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}